SHORTENING THE DOSING INTERVAL OR DOSE ESCALATION OF BIOLOGICAL DMARDS SUPPRESSED RESIDUAL ULTRASOUND SYNOVITIS AND JOINT DESTRUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS -STARBOARD STUDY-

被引：0
作者：
Yamada, Y. [1 ]
Okano, T. [1 ]
Mamoto, K. [1 ]
Inui, K. [2 ]
Mandai, K. [2 ]
Koike, T. [3 ]
Nakamura, H. [1 ]
机构：
[1] Osaka City Univ, Orthoped, Sch Med, Osaka, Japan
[2] Saiseikai Nakatsu Hosp, Orthoped, Osaka, Japan
[3] Osaka City Univ, Ctr Senile Degenerat Disorders CSDD, Sch Med, Osaka, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.1698
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0340
引用
收藏
页码：1294 / 1295
页数：2
相关论文
共 3 条
  • [1] Prevalence of ultrasound-detected residual synovitis and risk of relapse and structural progression in rheumatoid arthritis patients in clinical remission: a systematic review and meta-analysis
    Huong Nguyen
    Ruyssen-Witrand, Adeline
    Gandjbakhch, Frederique
    Constantin, Arnaud
    Foltz, Violaine
    Cantagrel, Alain
    [J]. RHEUMATOLOGY, 2014, 53 (11) : 2110 - 2118
  • [2] A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: Results of the 12-week double-blind period
    Ogata, Atsushi
    Tanaka, Yoshiya
    Ishii, Tomonori
    Kaneko, Motohide
    Miwa, Hiroko
    Ohsawa, Shino
    [J]. MODERN RHEUMATOLOGY, 2018, 28 (01) : 76 - 84
  • [3] Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis
    Takeuchi, Tsutomu
    Miyasaka, Nobuyuki
    Tatsuki, Yoshihiko
    Yano, Toshiro
    Yoshinari, Toru
    Abe, Tohru
    Koike, Takao
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (07) : 1208 - 1215
1